QA: Metavia Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2019_Metavia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Condensed Statements of Comprehensive Loss': 8, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 1}}

Graph

Absolute values for 0001638287, Metavia Inc

  xvar xval
0 AssetsCurrent 19,686,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 8,000
4 LiabilitiesCurrent 11,919,000
5 LiabilitiesNoncurrent 1,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,493,000
9 ResearchAndDevelopmentExpense 14,312,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -832,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 19,694,000
1 Liabilities 11,920,000
2 Expenses 22,805,000
3 Revenues 0
4 StockholdersEquity 7,774,000
5 NetIncome -23,637,000
6 ComprehensiveNetIncome -23,637,000
7 BaseVar 27,625,500
8 EconomicCapitalRatiobeforeLimitedLiability -0.423
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time